Hippocampal and Cognitive Aging across the Lifespan: A Bioenergetic Shift Precedes and Increased Cholesterol Trafficking Parallels Memory Impairment
Open Access
- 11 February 2009
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (6) , 1805-1816
Abstract
Multiple hippocampal processes and cognitive functions change with aging or Alzheimer's disease, but the potential triggers of these aging cascades are not well understood. Here, we quantified hippocampal expression profiles and behavior across the adult lifespan to identify early aging changes and changes that coincide with subsequent onset of cognitive impairment. Well powered microarray analyses (N= 49 arrays), immunohistochemistry, and Morris spatial maze learning were used to study male F344 rats at five age points. Genes that changed with aging (by ANOVA) were assigned to one of four onset age ranges based on template pattern matching; functional pathways represented by these genes were identified statistically (Gene Ontology). In the earliest onset age range (3–6 months old), upregulation began for genes in lipid/protein catabolic and lysosomal pathways, indicating a shift in metabolic substrates, whereas downregulation began for lipid synthesis, GTP/ATP-dependent signaling, and neural development genes. By 6–9 months of age, upregulation of immune/inflammatory cytokines was pronounced. Cognitive impairment first appeared in the midlife range (9–12 months) and coincided and correlated primarily with midlife upregulation of genes associated with cholesterol trafficking (apolipoprotein E), myelinogenic, and proteolytic/major histocompatibility complex antigen-presenting pathways. Immunolabeling revealed that cholesterol trafficking proteins were substantially increased in astrocytes and that myelination increased with aging. Together, our data suggest a novel sequential model in which an early-adult metabolic shift, favoring lipid/ketone body oxidation, triggers inflammatory degradation of myelin and resultant excess cholesterol that, by midlife, activates cholesterol transport from astrocytes to remyelinating oligodendrocytes. These processes may damage structure and compete with neuronal pathways for bioenergetic resources, thereby impairing cognitive function.Keywords
This publication has 62 references indexed in Scilit:
- Oxidant‐induced Changes in Mitochondria and Calcium Dynamics in the Pathophysiology of Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 2008
- Estrogen regulation of glucose metabolism and mitochondrial function: Therapeutic implications for prevention of Alzheimer's diseaseAdvanced Drug Delivery Reviews, 2008
- PPARγ Agonists as Therapeutics for the Treatment of Alzheimer's DiseaseNeurotherapeutics, 2008
- A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptidesNature Neuroscience, 2008
- Changes in transcription within the CA1 field of the hippocampus are associated with age-related spatial learning impairmentsNeurobiology of Learning and Memory, 2007
- Interleukin-1ß and Caspase-1: Players in the Regulation of Age-related Cognitive DysfunctionReviews in the Neurosciences, 2007
- Early and Simultaneous Emergence of Multiple Hippocampal Biomarkers of Aging Is Mediated by Ca2+-Induced Ca2+ReleaseJournal of Neuroscience, 2006
- The Metabolic Syndrome, Inflammation, and Risk of Cognitive DeclineJAMA, 2004
- Protective Effect of Practice on Cognition during Aging: Implications for Predictive Characteristics of Performance and Efficacy of PracticeNeurobiology of Learning and Memory, 2002
- Effects of aging on myelinated nerve fibers in monkey primary visual cortexJournal of Comparative Neurology, 2000